共 145 条
[1]
Seferovic PM(2019)Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 21 1169-1186
[2]
Ponikowski P(2017)Global public health burden of heart failure Card Fail Rev 3 7-25
[3]
Anker SD(2014)Heart failure: preventing disease and death worldwide ESC Heart Fail 1 4-28
[4]
Bauersachs J(2021)Polypharmacy definition and prevalence in heart failure: a systematic review Heart Fail Rev 27 1-418
[5]
Chioncel O(2015)Development of an aggregated system for classifying causes of drug-related problems Ann Pharmacother 49 405-730
[6]
Cleland JG(2021)Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation Int J Clin Pharm 43 726-333
[7]
Savarese G(2000)Drug-related problems in hospitalised patients Drug Saf 22 321-21
[8]
Lund LH(2014)What puts heart failure patients at risk for poor medication adherence? Patient Prefer Adherence 8 1007-280
[9]
Ponikowski P(2020)Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia PLoS ONE 15 e0237781-24
[10]
Anker SD(2018)Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia PLoS ONE 13 e0206120-2838